These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9661034)

  • 1. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.
    Martínez-Martínez L; García I; Ballesta S; Benedí VJ; Hernández-Allés S; Pascual A
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1850-2. PubMed ID: 9661034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.
    Martínez-Martínez L; Pascual A; Conejo Mdel C; García I; Joyanes P; Doménech-Sánchez A; Benedí VJ
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3926-32. PubMed ID: 12435697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae.
    Chevalier J; Pagès JM; Eyraud A; Malléa M
    Biochem Biophys Res Commun; 2000 Aug; 274(2):496-9. PubMed ID: 10913366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition.
    Tavío M; Vila J; Ruiz J; Amicosante G; Franceschini N; Martín-Sánchez AM; de Anta MT
    J Antimicrob Chemother; 2000 Apr; 45(4):521-4. PubMed ID: 10747831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Rydberg J; Larsson C; Miörner H
    Scand J Infect Dis; 1994; 26(3):317-20. PubMed ID: 7939432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
    Miguères ML; Ronco E; Guenounou M
    Pathol Biol (Paris); 1990 May; 38(5):385-9. PubMed ID: 2195447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.
    López-Brea M; Alarcón T
    Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):345-7. PubMed ID: 2197092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections.
    Deguchi T; Kawamura T; Yasuda M; Nakano M; Fukuda H; Kato H; Kato N; Okano Y; Kawada Y
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1609-11. PubMed ID: 9210697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a new fluoroquinolone, AF3013 (the active metabolite of prulifloxacin), on macrophage functions against Klebsiella pneumoniae: an in vitro comparison with pefloxacin.
    Tullio V; Cuffini AM; Bonino A; Palarchio AI; Roana J; Mandras N; Rossi V; Carlone NA
    J Antimicrob Chemother; 2000 Aug; 46(2):241-7. PubMed ID: 10933647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
    Yoshida S; Kojima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Feb; 35(2):368-70. PubMed ID: 2024969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteins.
    Deguchi T; Yasuda M; KawamuraT ; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Kawada Y
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2544-6. PubMed ID: 9371364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
    Cohen SP; McMurry LM; Hooper DC; Wolfson JS; Levy SB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1318-25. PubMed ID: 2679373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
    Chamberland S; Bayer AS; Schollaardt T; Wong SA; Bryan LE
    Antimicrob Agents Chemother; 1989 May; 33(5):624-34. PubMed ID: 2502066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
    Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
    Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the emergence of resistance to lomefloxacin in vitro.
    Kanematsu M; Greenwood D
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):741-5. PubMed ID: 2506046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pefloxacin and immunity: cellular uptake, potentiation of macrophage phagocytosis and intracellular bioactivity for Klebsiella pneumoniae.
    Cuffini AM; Tullio V; Fazari S; Allocco A; Carlone NA
    Int J Tissue React; 1992; 14(3):131-9. PubMed ID: 1446977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae.
    Chen FJ; Lauderdale TL; Ho M; Lo HJ
    Microb Drug Resist; 2003; 9(3):265-71. PubMed ID: 12959405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.